Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
Viseven, a life sciences technology partner powering the end-to-end commercial content supply chain, announced its participation in the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program. The global co-sell initiative connects qualified software partners with AWS sales teams to support joint customer engagement and scalable cloud-based innovation.
Through the program, Viseven expands its ability to deliver enterprise-grade, AI-enabled commercial content solutions to pharmaceutical and life sciences organizations worldwide. The collaboration enables streamlined procurement via AWS Marketplace, coordinated go-to-market execution, and accelerated global deployment of compliant omnichannel engagement capabilities.
“Joining the AWS ISV Accelerate Program strengthens our ability to bring scalable, intelligent commercial content operations to life sciences organizations globally,” said Nataliya Andreychuk, Co-founder and CEO of Viseven. “By combining Viseven’s domain expertise with AWS cloud and AI capabilities, we are enabling faster market execution, compliant engagement, and measurable business impact for our customers.”
The AWS ISV Accelerate Program provides Viseven with co-sell support and benefits to meet customer needs through collaboration with AWS field sellers globally. Co-selling provides better customer outcomes and assures mutual commitment from AWS and its partners.
Participation in the AWS ISV Accelerate Program requires partners to meet rigorous architectural, security, and customer success standards. Viseven successfully completed the technical validation and demonstrated proven customer outcomes across multiple life sciences markets.
Viseven is a global life sciences technology company that powers end-to-end commercial content operations for pharmaceutical organizations. The company integrates domain expertise, AI-driven content solutions, and cloud-based delivery to enable compliant, scalable, and efficient engagement across the entire product lifecycle. Viseven supports the full commercial content workflow—from market insights and modular content creation to medical, legal, and regulatory (MLR) review, omnichannel distribution, and field enablement—helping clients accelerate time-to-market and optimize global commercial operations.
